- Home
- FICO vs ONC Comparison
FICO vs ONC Comparison
Compare FICO & ONC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FICO | ONC |
|---|---|---|
| Founded | 1956 | 2010 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.2B | 34.8B |
| IPO Year | 1987 | N/A |
Fundamental Metrics
Financial Performance| Metric | FICO | ONC |
|---|---|---|
| Price | $1,555.58 | $338.98 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 12 |
| Target Price | ★ $2,016.50 | $369.50 |
| AVG Volume (30 Days) | 212.6K | ★ 291.5K |
| Earning Date | 01-28-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.78 | N/A |
| EPS | ★ 26.54 | 0.58 |
| Revenue | $1,990,869,000.00 | ★ $4,972,687,000.00 |
| Revenue This Year | $24.87 | $895.40 |
| Revenue Next Year | $17.26 | $22.04 |
| P/E Ratio | ★ $57.86 | $584.29 |
| Revenue Growth | 15.91 | ★ 50.43 |
| 52 Week Low | $1,300.00 | $196.45 |
| 52 Week High | $2,217.60 | $385.22 |
Technical Indicators
Market Signals| Indicator | FICO | ONC |
|---|---|---|
| Relative Strength Index (RSI) | 38.20 | 55.41 |
| Support Level | $1,493.31 | $325.10 |
| Resistance Level | $1,635.00 | $344.81 |
| Average True Range (ATR) | 54.14 | 11.44 |
| MACD | -9.57 | 1.83 |
| Stochastic Oscillator | 30.25 | 69.04 |
Price Performance
Historical ComparisonAbout FICO Fair Isaac Corproation
Founded in 1956, Fair Isaac Corporation is a leading applied analytics company. Fair Isaac is primarily known for its FICO credit scores, which is a widely used industry benchmark to determine the creditworthiness of an individual consumer. The firm's US-centric credit scores business accounts for most of the firm's revenue and profits and consists of business-to-business and business-to-consumer services. In addition to scores, Fair Isaac also sells software primarily to financial institutions for areas such as analytics, decision-making, customer workflows, and fraud.
About ONC BeiGene Ltd. American Depositary Shares
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.